GIP
CLSD

Granite Investment Partners’s Clearside Biomedical CLSD Stock Holding History

Granite Investment Partners’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,068
Closed -$533K – 303
2017
Q3 		$533K Sell
4,068
-2,128
-34% -$260K 0.03% 268
2017
Q2 		$847K Buy
6,196
+2,651
+75% +$318K 0.06% 248
2017
Q1 		$423K Buy
+3,545
New +$418K 0.03% 282

Other funds holding CLSD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Granite Investment Partners's CLSD Position: Q4 2017 in Review

Granite Investment Partners sold out of Clearside Biomedical (CLSD) in Q4 2017, closing a stake of 4,068 shares — an estimated $533K sold.

Granite Investment Partners first reported a position in CLSD in Q1 2017 and held it in 3 quarters. The position peaked at $847K in Q2 2017. 54 funds tracked by Wall St. Rank hold CLSD as of Q4 2017.

  • Granite Investment Partners reported no remaining Clearside Biomedical position as of Q4 2017 after selling out during the quarter.
  • Granite Investment Partners sold 4,068 Clearside Biomedical shares in Q4 2017, an estimated $533K.
  • Granite Investment Partners first reported a position in Clearside Biomedical in Q1 2017 and held it in 3 quarters.
  • Granite Investment Partners's Clearside Biomedical position peaked at $847K in Q2 2017.
  • 54 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2017.

Based on Granite Investment Partners's 13F filing for Q4 2017, filed 1 Feb 2018.